Lee Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-317
Closed -$25.7K 425
2023
Q4
$25.7K Buy
317
+84
+36% +$6.54K ﹤0.01% 286
2023
Q3
$17.5K Hold
233
﹤0.01% 322
2023
Q2
$18K Buy
233
+130
+126% +$10.4K ﹤0.01% 322
2023
Q1
$8.55K Sell
103
-19
-16% -$1.57K ﹤0.01% 447
2022
Q4
$10.5K Hold
122
﹤0.01% 454
2022
Q3
$7K Buy
122
+41
+51% +$2.58K ﹤0.01% 493
2022
Q2
$5K Buy
81
+37
+84% +$2.29K ﹤0.01% 555
2022
Q1
$3K Sell
44
-2,180
-98% -$139K ﹤0.01% 573
2021
Q4
$161K Buy
2,224
+60
+3% +$4.13K 0.03% 155
2021
Q3
$151K Hold
2,164
0.03% 156
2021
Q2
$149K Sell
2,164
-102
-5% -$6.81K 0.03% 157
2021
Q1
$146K Buy
2,266
+1
+0% +$64 0.03% 151
2020
Q4
$132K Buy
2,265
+101
+5% +$6.09K 0.03% 137
2020
Q3
$137K Hold
2,164
0.04% 135
2020
Q2
$166K Hold
2,164
0.05% 128
2020
Q1
$162K Buy
+2,164
New +$150K 0.05% 111
2019
Q2
Sell
-600
Closed -$39K 526
2019
Q1
$39K Hold
600
0.01% 203
2018
Q4
$38K Hold
600
0.01% 197
2018
Q3
$46K Buy
600
+167
+39% +$12.6K 0.01% 195
2018
Q2
$31K Buy
433
+1
+0.2% +$71 0.01% 296
2018
Q1
$32K Buy
432
+286
+196% +$22.7K 0.01% 296
2017
Q4
$10K Buy
146
+112
+329% +$8.51K ﹤0.01% 323
2017
Q3
$3K Sell
34
-30
-47% -$2.29K ﹤0.01% 435
2017
Q2
$5K Buy
+64
New +$4.26K ﹤0.01% 398

Other funds holding GILD

Lee Financial's GILD Position: Q1 2024 in Review

Lee Financial sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 317 shares — an estimated $25.7K sold.

Lee Financial first reported a position in GILD in Q2 2017 and held it in 24 quarters. The position peaked at $166K in Q2 2020. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Lee Financial reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 317 Gilead Sciences shares in Q1 2024, an estimated $25.7K.
  • Lee Financial first reported a position in Gilead Sciences in Q2 2017 and held it in 24 quarters.
  • Lee Financial's Gilead Sciences position peaked at $166K in Q2 2020.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.